Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460731 · ClinicalTrials.gov registry record · Phase 1
Young Plasma Transfusions for Progressive Supranuclear Palsy
A Phase 1 study of Progressive Supranuclear Palsy, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02460731 is a Phase 1 study of Progressive Supranuclear Palsy that has completed, run by University of California, San Francisco. The registered enrollment target is 6 participants, below the 452-participant average among 18 other Progressive Supranuclear Palsy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02460731, a Phase 1 study of Progressive Supranuclear Palsy, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase 1, multi-center, open-label study of the safety, tolerability, pharmacodynamics, and preliminary efficacy of young (\<30 years of age) healthy male donor plasma transfusions in patients with PSP. Up to 10 subjects will receive once monthly 4-unit transfusions of young healthy male donor plasma for 6 months.
Conditions Studied
Interventions
- BIOLOGICAL Fresh Frozen Plasma
Study Locations (1)
California
- University of California, San Francisco, Memory and Aging Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460731
The ClinicalTrials.gov registry entry for NCT02460731 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 18 other Progressive Supranuclear Palsy trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Progressive Supranuclear Palsy appearing as the primary indexed condition, and to 1 intervention - of which Fresh Frozen Plasma is the first listed.
NCT02460731 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02460731 about?
NCT02460731 is a clinical study titled "Young Plasma Transfusions for Progressive Supranuclear Palsy". This is a phase 1, multi-center, open-label study of the safety, tolerability, pharmacodynamics, and preliminary efficacy of young (\<30 years of age) healthy male donor plasma transfusions in patients with PSP. Up to 10 subjects will receive once monthly 4-unit transfusions of young healthy male do...
What is the current status of trial NCT02460731?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2015-05. Estimated completion is 2019-12.
What conditions does trial NCT02460731 study?
This clinical trial studies the following conditions: Progressive Supranuclear Palsy.
What interventions are being tested in trial NCT02460731?
The interventions under investigation include: Fresh Frozen Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT02460731?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02460731 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Progressive Supranuclear Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
-
Gait Analysis in Neurological Disease
RECRUITING
-
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
RECRUITING · NA
-
Modifiable Variables in Parkinsonism (MVP)
RECRUITING
-
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
RECRUITING
-
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.